These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23915256)

  • 21. Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool.
    Rupert DJ; Squiers LB; Renaud JM; Whitehead NS; Osborn RJ; Furberg RD; Squire CM; Tzeng JP
    Patient Educ Couns; 2013 Aug; 92(2):188-96. PubMed ID: 23664232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.
    Sobol H; Bignon YJ; Bonaiti C; Cuisenier J; Lasset C; Lortholary A; Noguès C; Stoppa-Lyonnet D; Eisinger F
    Dis Markers; 1999 Oct; 15(1-3):15-29. PubMed ID: 10595246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation-effectiveness trial of systematic family health history based risk assessment and impact on clinical disease prevention and surveillance activities.
    Wu RR; Myers RA; Neuner J; McCarty C; Haller IV; Harry M; Fulda KG; Dimmock D; Rakhra-Burris T; Buchanan A; Ginsburg GS; Orlando LA
    BMC Health Serv Res; 2022 Dec; 22(1):1486. PubMed ID: 36474257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The GRAIDS Trial: the development and evaluation of computer decision support for cancer genetic risk assessment in primary care.
    Emery J
    Ann Hum Biol; 2005; 32(2):218-27. PubMed ID: 16096220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.
    Cragun D; Beckstead J; Farmer M; Hooker G; Dean M; Matloff E; Reid S; Tezak A; Weidner A; Whisenant JG; Pal T
    BMC Cancer; 2021 Oct; 21(1):1099. PubMed ID: 34645413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a family history screening questionnaire in Australian primary care.
    Emery JD; Reid G; Prevost AT; Ravine D; Walter FM
    Ann Fam Med; 2014; 12(3):241-9. PubMed ID: 24821895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer.
    Kallenberg FGJ; Aalfs CM; The FO; Wientjes CA; Depla AC; Mundt MW; Bossuyt PMM; Dekker E
    Fam Cancer; 2018 Jul; 17(3):371-380. PubMed ID: 28936633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial risk for common diseases in primary care: the Family Healthware Impact Trial.
    O'Neill SM; Rubinstein WS; Wang C; Yoon PW; Acheson LS; Rothrock N; Starzyk EJ; Beaumont JL; Galliher JM; Ruffin MT;
    Am J Prev Med; 2009 Jun; 36(6):506-14. PubMed ID: 19460658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CRISP-P study: feasibility of a self-completed colorectal cancer risk prediction tool in primary care.
    Harty EC; McIntosh JG; Bickerstaffe A; Hewabandu N; Emery JD
    Fam Pract; 2019 Nov; 36(6):730-735. PubMed ID: 31237329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Practice Facilitation and Academic Detailing Intervention Can Improve Cancer Screening Rates in Primary Care Safety Net Clinics.
    Mader EM; Fox CH; Epling JW; Noronha GJ; Swanger CM; Wisniewski AM; Vitale K; Norton AL; Morley CP
    J Am Board Fam Med; 2016; 29(5):533-42. PubMed ID: 27613786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usability testing of Avoiding Diabetes Thru Action Plan Targeting (ADAPT) decision support for integrating care-based counseling of pre-diabetes in an electronic health record.
    Chrimes D; Kitos NR; Kushniruk A; Mann DM
    Int J Med Inform; 2014 Sep; 83(9):636-47. PubMed ID: 24981988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.
    Hughes KS; Roche C; Campbell CT; Siegel N; Salisbury L; Chekos A; Katz MS; Edell E
    Breast J; 2003; 9(1):19-25. PubMed ID: 12558666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.
    Rodriguez JL; Thomas CC; Massetti GM; Duquette D; Avner L; Iskander J; Khoury MJ; Richardson LC
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(46):1291-1294. PubMed ID: 27880748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cancer genetics in eastern and central Europe.
    Olah E
    Dis Markers; 1999 Oct; 15(1-3):75-7. PubMed ID: 10595256
    [No Abstract]   [Full Text] [Related]  

  • 36. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.
    Medina-Lara A; Grigore B; Lewis R; Peters J; Price S; Landa P; Robinson S; Neal R; Hamilton W; Spencer AE
    Health Technol Assess; 2020 Nov; 24(66):1-332. PubMed ID: 33252328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computer support for recording and interpreting family histories of breast and ovarian cancer in primary care (RAGs): qualitative evaluation with simulated patients.
    Emery J; Walton R; Coulson A; Glasspool D; Ziebland S; Fox J
    BMJ; 1999 Jul; 319(7201):32-6. PubMed ID: 10390458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standards-Based Clinical Decision Support Platform to Manage Patients Who Meet Guideline-Based Criteria for Genetic Evaluation of Familial Cancer.
    Del Fiol G; Kohlmann W; Bradshaw RL; Weir CR; Flynn M; Hess R; Schiffman JD; Nanjo C; Kawamoto K
    JCO Clin Cancer Inform; 2020 Jan; 4():1-9. PubMed ID: 31951474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.